Leucadia National Corporation »

Summit Therapeutics shares owned by Leucadia National Corporation

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Leucadia National Corporation from 13F filings

Historical chart of Leucadia National Corporation investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Leucadia National Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Leucadia National Corporation

Quarter filed Position value Share count Share price at filing
2025-09-30 $310k 15k 20.66
2024-12-31 $803k 45k 17.85